Skip to main content
Erschienen in: Updates in Surgery 2/2010

01.10.2010 | Original Article

Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution

verfasst von: Marco Catarci, Leonardo Antonio Montemurro, Antonio Di Cintio, Sabrina Ghinassi, Luigi Coppola, Luigi Pinnarelli, Augusto Belardi, Maurizio Koch, Giovanni Battista Grassi

Erschienen in: Updates in Surgery | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

The optimal degree of lymph node dissection for gastric cancer is still matter of debate. Particularly, there are serious doubts about the reproducibility of extended lymph node dissection in western surgical units, and no studies to date have investigated factors influencing lymph node retrieval and examination during the learning curve. Univariate and multivariate retrospective analysis of 21 variables were carried out on a prospective series of 313 consecutive resections for gastric cancer performed by ten different surgeons, with lymph node retrieval and analysis performed by ten different pathologists. Endpoints were number of examined lymph nodes per patient, number of cases with inadequate nodal staging (<15 examined lymph nodes) and lymph node ratio (calculated as the absolute ratio between the number of metastatic and the number of examined lymph nodes). The number of examined lymph nodes per patient (mean ± SD 28.3 ± 14.1, median 26, range 2–78) was independently influenced by age, pN status, the type of gastric resection, the degree of lymph node dissection and single pathologist. There were 47 cases (15.0%) with incomplete nodal staging that was independently determined by the degree of lymph node dissection and by the pathologist. Lymph node ratio was independently influenced by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. The role of an experienced or dedicated pathologist should not be underevaluated in western series when dealing with lymph node retrieval and examination. Lymph node ratio appeared not to be significantly influenced by the number of examined lymph nodes, being independently influenced only by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. It could be therefore tested as a prognostic factor limiting the stage-migration phenomenon induced by extended lymph node dissection.
Literatur
1.
Zurück zum Zitat Maruyama K (1986) Surgical treatment and end result of gastric cancer. National Cancer Center Press, Tokyo Maruyama K (1986) Surgical treatment and end result of gastric cancer. National Cancer Center Press, Tokyo
2.
Zurück zum Zitat Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767–2773CrossRefPubMed Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767–2773CrossRefPubMed
3.
Zurück zum Zitat Siewert JR, Bottcher K, Roder D, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018CrossRefPubMed Siewert JR, Bottcher K, Roder D, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018CrossRefPubMed
4.
Zurück zum Zitat Siewert JR, Kestlmeier R, Busch R et al (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83:1144–1147CrossRefPubMed Siewert JR, Kestlmeier R, Busch R et al (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83:1144–1147CrossRefPubMed
5.
Zurück zum Zitat Jaehne J, Meyer H-J, Mascher H, Geerlings H, Pichlmayr R (1992) Lymphadenectomy in gastric carcinoma. Arch Surg 127:290–294PubMed Jaehne J, Meyer H-J, Mascher H, Geerlings H, Pichlmayr R (1992) Lymphadenectomy in gastric carcinoma. Arch Surg 127:290–294PubMed
6.
Zurück zum Zitat Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B (2006) Extended lymph-node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 93:394–400CrossRefPubMed Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B (2006) Extended lymph-node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 93:394–400CrossRefPubMed
7.
Zurück zum Zitat De Giuli M, Sasako M, Calgaro M et al (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303–308 De Giuli M, Sasako M, Calgaro M et al (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303–308
8.
Zurück zum Zitat Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F (2007) Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 14:25–33CrossRefPubMed Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F (2007) Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 14:25–33CrossRefPubMed
9.
Zurück zum Zitat Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 And D2 resections for gastric cancer: long-term result of the MRC randomised controlled surgical trial. Br J Surg 79:1522–1530 Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 And D2 resections for gastric cancer: long-term result of the MRC randomised controlled surgical trial. Br J Surg 79:1522–1530
10.
Zurück zum Zitat Bonenkamp JJ, Hermans J, Sasako M, Van De Velde CJH, for the Dutch Gastric Cancer Group (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908–914CrossRefPubMed Bonenkamp JJ, Hermans J, Sasako M, Van De Velde CJH, for the Dutch Gastric Cancer Group (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908–914CrossRefPubMed
11.
Zurück zum Zitat McCulloch P, Niita EM, Kazi H, Gama-Rodriguez J (2005) Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 92:5–13CrossRefPubMed McCulloch P, Niita EM, Kazi H, Gama-Rodriguez J (2005) Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 92:5–13CrossRefPubMed
12.
Zurück zum Zitat Sobin LH, Wittekind CH, International Union Against Cancer (UICC) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York Sobin LH, Wittekind CH, International Union Against Cancer (UICC) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York
13.
Zurück zum Zitat Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78:825–827CrossRefPubMed Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78:825–827CrossRefPubMed
14.
Zurück zum Zitat Sharma D, Thakur A, Toppo S, Chandrakar SK (2005) Lymph node counts in Indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach. Asian J Surg 28:116–120CrossRefPubMed Sharma D, Thakur A, Toppo S, Chandrakar SK (2005) Lymph node counts in Indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach. Asian J Surg 28:116–120CrossRefPubMed
15.
Zurück zum Zitat Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94:2862–2866CrossRefPubMed Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94:2862–2866CrossRefPubMed
16.
Zurück zum Zitat Baxter NN, Tuttle TM (2005) Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12:981–987CrossRefPubMed Baxter NN, Tuttle TM (2005) Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12:981–987CrossRefPubMed
17.
Zurück zum Zitat Coburn NG, Swallow CJ, Kiss A, Law C (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRefPubMed Coburn NG, Swallow CJ, Kiss A, Law C (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRefPubMed
18.
Zurück zum Zitat Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1:10–24CrossRefPubMed Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1:10–24CrossRefPubMed
19.
Zurück zum Zitat Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139–146CrossRefPubMed Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139–146CrossRefPubMed
20.
Zurück zum Zitat Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed
21.
Zurück zum Zitat Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K (1995) Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19:532–536CrossRefPubMed Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K (1995) Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19:532–536CrossRefPubMed
22.
Zurück zum Zitat Draper NR, Smith H (1998) Applied regression analysis, 3rd edn. Wiley, New York Draper NR, Smith H (1998) Applied regression analysis, 3rd edn. Wiley, New York
23.
Zurück zum Zitat Davis PA, Sano T (2001) The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol Hematol 40:77–94CrossRefPubMed Davis PA, Sano T (2001) The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol Hematol 40:77–94CrossRefPubMed
24.
Zurück zum Zitat Catarci M, Guadagni S, Zaraca F et al (1998) Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol 5:580–584CrossRefPubMed Catarci M, Guadagni S, Zaraca F et al (1998) Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol 5:580–584CrossRefPubMed
25.
Zurück zum Zitat Candela FC, Urmacher C, Brennan MF (1990) Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer 66:1828–1832CrossRefPubMed Candela FC, Urmacher C, Brennan MF (1990) Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer 66:1828–1832CrossRefPubMed
26.
Zurück zum Zitat Koren R, Kyzer S, Levin I, Klein B, Halpern M, Rath-Wolfson L, Paz A, Melloul MM, Mishali M, Gal R (1997) Lymph node revealing solution: a new method for lymph node sampling. Results in gastric adenocarcinoma. Oncol Rep 5:341–344 Koren R, Kyzer S, Levin I, Klein B, Halpern M, Rath-Wolfson L, Paz A, Melloul MM, Mishali M, Gal R (1997) Lymph node revealing solution: a new method for lymph node sampling. Results in gastric adenocarcinoma. Oncol Rep 5:341–344
27.
Zurück zum Zitat Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH (2009) Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg 13:1233–1237CrossRefPubMed Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH (2009) Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg 13:1233–1237CrossRefPubMed
28.
Zurück zum Zitat Hammond EH, Henson DE (1995) The role of pathologists in cancer patient staging. Cancer Committee. Am J Clin Pathol 103:679–680PubMed Hammond EH, Henson DE (1995) The role of pathologists in cancer patient staging. Cancer Committee. Am J Clin Pathol 103:679–680PubMed
29.
Zurück zum Zitat Noda N, Sasako M, Yamaguchi N, Nakanishi Y (1998) Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg 85:831–834CrossRefPubMed Noda N, Sasako M, Yamaguchi N, Nakanishi Y (1998) Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg 85:831–834CrossRefPubMed
30.
Zurück zum Zitat Marchet A, Morcellin S, Ambrosi et al (2007) The ratio between metastatic and examined lymph nodes (N ratio) is and independent prognostic factor in gastric cancer regardless the type of lymphadenectomy. Ann Surg 245:543–552 Marchet A, Morcellin S, Ambrosi et al (2007) The ratio between metastatic and examined lymph nodes (N ratio) is and independent prognostic factor in gastric cancer regardless the type of lymphadenectomy. Ann Surg 245:543–552
31.
Zurück zum Zitat Cheong JH, Hyung WJ, Shen JG et al (2006) The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol 13:377–385CrossRefPubMed Cheong JH, Hyung WJ, Shen JG et al (2006) The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol 13:377–385CrossRefPubMed
32.
Zurück zum Zitat Xu D, Geng Q, Long Z et al (2009) Positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 16:319–326CrossRefPubMed Xu D, Geng Q, Long Z et al (2009) Positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 16:319–326CrossRefPubMed
Metadaten
Titel
Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution
verfasst von
Marco Catarci
Leonardo Antonio Montemurro
Antonio Di Cintio
Sabrina Ghinassi
Luigi Coppola
Luigi Pinnarelli
Augusto Belardi
Maurizio Koch
Giovanni Battista Grassi
Publikationsdatum
01.10.2010
Verlag
Springer Milan
Erschienen in
Updates in Surgery / Ausgabe 2/2010
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-010-0017-8

Weitere Artikel der Ausgabe 2/2010

Updates in Surgery 2/2010 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.